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Background: Gold nanocages have been widely used as multifunctional platforms for drug
and gene delivery, as well as photothermal agents for cancer therapy. However, their
potential as gene delivery systems for cancer treatment has been reported in combination
with chemotherapeutics and photothermal therapy, but not in isolation so far. The purpose of
this work was to investigate whether the conjugation of gold nanocages with the cancer
targeting ligand lactoferrin, polyethylene glycol and polyethylenimine could lead to
enhanced transfection efficiency on prostate cancer cells in vitro, without assistance of
external stimulation.
Methods: Novel lactoferrin-bearing gold nanocages conjugated to polyethylenimine and
polyethylene glycol have been synthesized and characterized. Their transfection efficacy and
cytotoxicity were assessed on PC-3 prostate cancer cell line following complexation with
a plasmid DNA.
Results: Lactoferrin-bearing gold nanocages, alone or conjugated with polyethylenimine
and polyethylene glycol, were able to condense DNA at conjugate:DNA weight ratios 5:1
and higher. Among all gold conjugates, the highest gene expression was obtained following
treatment with gold complex conjugated with polyethylenimine and lactoferrin, at weight
ratio 40:1, which was 1.71-fold higher than with polyethylenimine. This might be due to the
increased DNA cellular uptake observed with this conjugate, by up to 8.65-fold in compar
ison with naked DNA.
Conclusion: Lactoferrin-bearing gold nanocages conjugates are highly promising gene
delivery systems to prostate cancer cells.
Keywords: gold nanocages, cancer targeting, transfection efficacy, lactoferrin,
polethylenimine, polyethylene glycol
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Gold nanoparticles have been widely used in biomedical applications due to their
low toxicity, tunable size, unique physicochemical properties and ease of surface
modification with targeting moieties such as proteins, peptides and antibodies to
specifically target cancer cells.1–3 In addition to these properties, they have been
particularly attractive for gene delivery, owing to their ability to condense nucleic
acids via electrostatic interactions or through the conjugation of nucleic acids to
their surface via thiol linkages.4–7 Among these nanoparticles, gold nanocages are
a novel class of gold nanomaterial with cage shape, hollow interiors and porous
wall that allow them to load drugs, in addition to their ability to convert light into
heat at near-infrared region (700–900 nm), making them appropriate candidates for
biomedical applications and photothermal cancer therapy.8–10 Due to the unique
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Graphical Abstract

structure of gold nanocages, drugs can be loaded into the
hollow interiors of the nanocages that are then coated by
a shell of thermo-sensitive polymers, as previously
reported.11,12 The polymer shell prevented the drug from
being released until external thermal stimuli such as nearinfrared light or high-intensity-focused ultrasound were
presented.
However, the recent advances of the use of gold nano
cages in controlled drug delivery and photothermal cancer
therapy led to the need to explore the possibility of using
gold nanocages for targeted gene delivery for cancer treat
ment, without the assistance of external stimulations or
combination with chemotherapeutics. Hence, we propose
to conjugate the surface of gold nanocages with cancertargeting moieties such as lactoferrin and to functionalize
the nanocages surface with cationic polymers, and inves
tigate whether the conjugated gold nanocages could con
dense the DNA on their surface and facilitate gene
expression on prostate cancer cells in vitro. Recently,
cancer-targeting ligand lactoferrin (Lf), whose receptors
are overexpressed in most cancers, has been shown to be
highly promising in enhancing the therapeutic efficacy of
gene cancer therapy as a result of significant increase of
gene expression in tumors after intravenous
administration.13–15 Cationic polymers, such as polyethy
lenimine (PEI), have been widely used to generate posi
tively charged nanoparticles due to its capacity to complex
DNA or RNA and to its high transfection efficiency.7,16
Furthermore, low molecular weight PEI resulted in
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decreased cytotoxicity and enhanced transfection efficacy
compared to its high molecular weight counterpart.17 The
conjugation of polyethylene glycol (PEG) to nanoparticles
is another approach that has recently contributed to
enhance transfection efficiency while reducing the cyto
toxicity associated with nanoparticles through shielding
their charges and preventing their interactions with plasma
proteins.18–20
The objectives of this study were therefore to (1)
synthesize and characterize lactoferrin-bearing gold nano
cages, PEG-conjugated, lactoferrin-bearing gold nano
cages and PEI-conjugated, lactoferrin-bearing gold
nanocages, (2) to evaluate their DNA condensation effi
ciency following complexation with a plasmid DNA, and
(3) to assess the cell viability, transfection efficacy and
cellular uptake of these conjugates complexed with DNA
on PC-3 prostate cancer cells.

Materials and Methods
Cell Lines and Reagents
Lactoferrin (Lf), branched polyethyleneimine (PEI, Mw
800 Da), diethylene glycol (DEG), silver trifluoroacetate
(CF3COOAg), sodium hydrosulfide hydrate (NaSH),
hydrogen tetrachloroaurate (III) hydrate (HAuCl4), aqu
eous hydrochloric acid solution (HCl, 37%), polyvinyl
pyrrolidone (PVP, Mw 55,000 Da), sodium chloride
(NaCl) and deionized (DI) water with a resistivity of
18.2 MΩ·cm were purchased from Sigma Aldrich (Poole,
UK). Thiol PEG amine (HS-PEG3.5K-NH2) was from
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JenKem Technology (Plano, TX). N-[1-(2,3-Dioleoyloxy)
propyl]-N,N,N-trimethylammonium
methylsulfate
(DOTAP) liposomal transfection reagent was purchased
from Roche (Burgess Hill, UK). The expression plasmid
encoding β-galactosidase (pCMVsport β-galactosidase)
was obtained from Invitrogen (Paisley, UK). It was pur
ified using an Endotoxin-free Giga Plasmid Kit (Qiagen,
Hilden, Germany). Minimum Modified Eagle Medium
(MEM) and fetal bovine serum (FBS), L-glutamine and
penicillin-streptomycin were obtained from Life
Technologies (Paisley, UK). Vectashield® mounting med
ium containing 4′,6-diamidino-2-phenylindole (DAPI) was
ordered from Vector Laboratories (Peterborough, UK).
Label IT® Fluorescein Nucleic Acid Labeling Kit was
obtained from Cambridge Biosciences (Cambridge, UK).
Passive lysis buffer was purchased from Promega
(Southampton, UK). BioWare® androgen-irresponsive
PC-3M-luc-C6 human prostate adenocarcinoma that
expresses the firefly luciferase was purchased from
Caliper Life Sciences (Hopkinton, MA).

Synthesis and Characterization of Gold
Nanocages Conjugates
Synthesis of Silver Nanocubes
Silver nanocubes were synthesized via polyol reduction in
diethylene glycol (DEG) as previously reported.21 Briefly,
60 mL of DEG was added into 250 mL round-bottom
flask containing a magnetic stir bar and heated in an oil
bath at 150 °C for 30 min. The reagents were then pre
pared in DEG and added separately to the reaction flask.
Initially, NaSH solution (0.72 mL, 3 mM) was pipetted to
the flask. After 4 min, HCL solution (6 mL, 3 mM) was
added, followed by 15 mL of PVP solution (20 mg/mL).
After 2 min, CF3COOAg solution (4.8 mL, 282 mM) was
then added. The flask was closed loosely throughout the
entire process, except during the addition of the reagents.
The reaction was stopped after 90 min by placing the flask
in an ice water bath for 30 min. Then, 25 mL of the
mixture was transferred to 50 mL centrifuge tube and
mixed with 20 mL acetone, followed by centrifugation
at 9000 rpm (16,000 g) for 30 min. After removing the
supernatant, 20 mL of deionized (DI) water was added to
the remaining products then sonicated for 10 min using an
ultrasound bath sonicator. Next, the products were centri
fuged at 9000 rpm (16,000 g) for 10 min, followed by the
discarding of the supernatant and the sonication of the
remaining products with 20 mL of DI water. This process
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was repeated a further three times. The final products
were then dispersed in 20 mL of DI water and stored at
4 °C.

Synthesis of Gold Nanocages
Gold nanocages (AuNCs) were synthesized based on pre
viously published methods,22 with some modifications.
Briefly, 600 mL of polyvinyl pyrrolidone (PVP) solution
(1 mg/mL in DI water) was added to a 1 L round-bottom
flask containing a magnetic stir bar. Then, 60 mL of asprepared silver nanocubes were added to the flask and
heated at 100 °C, while stirring for 30 min. An aqueous
solution of 1 mM HAuCl4 (140 mL) was added to the
reaction flask via a syringe pump at a rate of 45 mL/h. The
reaction was stopped when the reaction sample attained
a blue color and exhibited UV-Vis absorption spectrum at
740 nm. The mixture was heated at 100 °C for another 15
min until the reaction color became stable. After cooling
down the flask to 25 °C, 20 mL of NaCl-saturated solution
(0.36 g/mL) was mixed with each 25 mL aliquots of the
mixture to remove AgCl. The products were then centri
fuged at 9000 rpm (16,000 g) for 30 min and washed with
20 mL of DI water after discarding the supernatant. This
process was repeated three times. The final products were
added to 20 mL of DI water and stored at 4 °C for further
use. Au concentration of gold nanocages was obtained via
inductively coupled plasma mass spectrometry (ICP-MS).
Briefly, 20 μL of AuNCs in DI water was digested in 180
μL aqua regia at 20 °C for 1 h. The mixture was further
diluted with DI water to a final aqua regia concentration of
2%. The Au concentration (μg/L) within the samples was
measured using the 197Au isotope and the 175Lu isotope
used as an internal standard for all measurements. All ICPMS measurements were performed in triplicate using an
Agilent 7700X® instrument (Agilent Technologies, Santa
Clara, US).

Synthesis of Lactoferrin-Bearing Gold Nanocages
(AuNCs-Lf)
The conjugation of lactoferrin (Lf) to AuNCs was done
with modifications from a previously reported method.23
Briefly, 8 mg of Lf was dissolved in 2 mL of 50 mM
sodium phosphate and 0.15 M sodium chloride buffer (pH
7.5) and reacted with 5-fold mole excess of 2-iminothio
lane (Traut’s reagent, 1 mg/mL in distilled water, 7.26
mM, 61.2 µL) for 75 min at 20 °C. The modified Lf was
purified using a Vivaspin-6 centrifuge tube with
a molecular weight cut-off (MWCO) of 5000 Da for 20
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min at 8000 rpm (14,000 g). Thiolated Lf (100 μL, 8 mg/
mL) was added to 1 mL of AuNCs, then vortexed and
incubated at 25 °C for 24 h. The final product was purified
twice with 1 mL of DI water using Vivaspin-6 centrifuge
tubes with a MWCO of 100,000 Da to remove any
unreacted AuNCs, before being freeze-dried.

Synthesis of PEG-Conjugated, Lactoferrin-Bearing
Gold Nanocages (AuNCs-Lf-PEG)
Thiol-PEG3.5K-amine aqueous solution (100 µL, 2 mM)
was added to 1 mL of lactoferrin-bearing AuNCs (AuNCsLf) suspension and vortexed for 10 s. The mixture was
then incubated at 25 °C for 24 h. The final product was
purified twice with DI water using Vivaspin-6 centrifuge
tubes with MWCO of 100,000 Da to remove any
unreacted PEG, before being freeze-dried.

Synthesis of PEI-Conjugated, Lactoferrin-Bearing
Gold Nanocages (AuNCs-Lf-PEI)
The thiolation of polyethyleneimine (PEI) was performed
with modifications of a previously reported method.24 The
formation of thiolated PEI was carried out by reacting the
PEI with 2-fold moles excess of 2-iminothiolane (Traut’s
reagent). PEI was dissolved in PBS at a concentration of
10 mg/mL (12.5 mM). Traut’s reagent (3.44 mg/mL in
PBS, 25 mM, 4.28 mL) was added to PEI solution
(10 mg/mL in PBS, 12.5 mM, 4.28 mL) and vortexed for
5 s. The reaction mixture was then incubated at 25 °C for
24 h. The final compound was purified using benzoylated
dialysis tubing with a MWCO of 2000 Da at room tem
perature (20–22 °C) against 2 L of distilled water and
changed twice during dialysis. After 24-hour dialysis, the
solution was freeze-dried for 48 hours using Christ Epsilon
2–4 LSC® freeze dryer (Osterode am Harz, Germany).
Thiolated PEI (10 mg/mL in PBS, 400 μL) was added
to each 1 mL of as-prepared AuNCs-Lf, vortexed for 5 s,
then incubated at 25 °C for 24 h. AuNCs-Lf-PEI was then
purified twice with 1 mL of DI water using a Vivaspin-6
centrifuge tube with a MWCO of 5000 Da for 20 min at
8000 rpm (14,000 g). The purified AuNCs-Lf-PEI conju
gate was freeze-dried for 48 hours.

Characterization of Gold Nanocages
Conjugates
Transmission Electron Microscopy
The morphology of AuNCs conjugates was examined using
transmission electron microscopy (TEM). Typically, 20 of
μL AuNCs conjugates samples were placed in carbon-
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coated 200-mesh copper grids and left to dry at 20 °C for
1 h. The samples were then visualized using a JEOL JEM1200EX® transmission electron microscope (Jeol, Tokyo,
Japan) operating at an accelerating voltage of 80 kV.

Circular Dichroism Spectrometer
The conjugation of Lf, Lf-PEG and Lf-PEI to AuNCs was
assessed using circular dichroism (CD) spectrometer
(Chirascan V100®, Applied Photophysics, Leatherhead,
UK). All samples were prepared at a concentration of
2 mg/mL in DI water. CD spectra were recorded using
a quartz cuvette with a path length of 10 mm over a range
of 190–900 nm, with a scan speed of 70 nm/min and
a bandwidth of 1 nm.

Fourier-Transform Infrared Spectrophotometer
(FTIR)
The infrared spectra of Lf-bearing AuNCs were carried out
using Fourier-transform infrared (FTIR) spectrophot
ometer equipped with attenuated total reflectance (ATR)
probe (IRSpirit® QATR-S, Shimadzu, Kyoto, Japan).
Transmission spectra were collected over a range of
4000–400 cm−1 at a resolution of 4 cm−1, then analyzed
with the LabSolutions IR® software (Shimadzu, Kyoto,
Japan).

UV-Vis Spectrometry Analysis
The formation of the AuNCs conjugates was further eval
uated by UV-Vis spectrometry analysis using a Varian
Cary® 50 Bio UV-visible spectrophotometer in the wave
length range of 300–900 nm. The UV-Vis spectrum of DI
water was adjusted as baseline prior to the measurement of
the samples.

Size and Zeta Potential Measurement
The size and zeta potential of AuNCs conjugates in DI
water were measured by photon correlation spectroscopy
and laser Doppler electrophoresis using a Malvern
Zetasizer Nano-ZS® (Malvern Instruments, Malvern, UK)
at 25 °C. All size and zeta-potential measurements were
conducted in triplicate with a He–Ne laser operating at
632.8 nm and a scattering angle of 173°.

Characterization of the Complexation of
AuNCs-Lf, AuNCs-Lf-PEG and
AuNCs-Lf-PEI Conjugates with DNA
Gel Retardation Assay
The ability of AuNCs conjugates to condense DNA was
assessed by agarose gel retardation assay. AuNCs
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conjugate complexes were prepared at various AuNCs
conjugate:DNA weight ratios from 0.5:1 to 40:1, with
a constant DNA concentration of 20 µg/mL. After mixing
with the loading buffer, the samples (15 µL) were loaded
on a 1X Tris-Borate-EDTA (TBE) (89 mM Tris base, 89
mM boric acid, 2 mM Na2-EDTA, pH 8.3) buffered 0.8%
(w/v) agarose gel containing ethidium bromide (0.4 µg/
mL), with 1x TBE as a running buffer. The DNA size
marker was HyperLadder I. The gel was run at 50 V for 1h
and then photographed under UV light.

Size and Zeta Potential of the Complexes
The size and zeta potential of the complexes in 5% (w/v)
glucose were measured for different AuNCs conjugates:
DNA weight ratios (0.5:1, 1:1, 5:1, 10:1, 20:1, 40:1) by
photon correlation spectroscopy and laser Doppler electro
phoresis at 37 °C using a Malvern Zetasizer Nano-ZS®
(Malvern Instruments, Malvern, UK). The DNA concen
tration (1 µg/mL) remained constant throughout the
experiment.

Cell Culture
PC-3-Luc prostate cancer cells were grown as monolayers
in Minimum Essential Medium (MEM) supplemented with
10% (v/v) fetal bovine serum, 1% (v/v) L-glutamine, and
0.5% (v/v) penicillin–streptomycin. The cell culture flasks
were kept at 37 °C in a 5% carbon dioxide humid
atmosphere.

Transfection
The transfection efficacy of the DNA complexed to
AuNCs conjugates was assessed using a β-galactosidase
assay. PC-3 cells were seeded at a concentration of 10,000
cells/well in 96-well plates and incubated for 24 h at 37 °C
in a 5% CO2 atmosphere. They were then treated with
AuNCs conjugates complexed with a plasmid DNA
encoding β-galactosidase, in quintuplicate at various
AuNCs conjugate:DNA weight ratios (0.5:1, 1:1, 2:1,
5:1, 10:1 20:1 and 40:1). Naked DNA was used as
a negative control, whereas DOTAP-DNA (weight ratio
5:1) served as a positive control. DNA concentration (0.5
μg/well) was maintained constant throughout the experi
ment. The cells were incubated for 72 h with the treatment
before analysis. They were then lysed with 1x passive
lysis buffer (PLB) (50 μL/well) for 20 min and then tested
for β-galactosidase expression.25 Briefly, 50 μL of the
assay buffer (2 mM magnesium chloride, 100 mM mer
captoethanol,
1.33
mg/mL
o-nitrophenylβ-
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D-galactosidase, 200 mM sodium phosphate buffer, pH
7.3) was added to each well containing the lysate, before
being incubated for 2 h at 37 °C. The absorbance of the
samples was subsequently read at 405 nm using
a Multiskan Ascent® plate reader (MTX Lab Systems,
Bradenton, FL).

Cellular Uptake
Quantitative Analysis
The quantification of cellular uptake of DNA complexed
with AuNCs conjugates was carried out by flow cytome
try. PC-3 cells were seeded at a density of 3×105 cells per
well in 6-well plates and grown at 37 °C for 24 h, before
being treated with fluorescein-labeled DNA (2.5 μg DNA
per well) alone or complexed with the conjugates at
AuNCs conjugate:DNA weight ratios of 0.5:1 and 40:1.
Untreated cells served as a negative control. After 24 h of
incubation with the treatments, each well was washed with
2 mL of PBS pH 7.4 twice. Single-cell suspensions were
then prepared (using 250 μL trypsin per well, followed by
500 μL medium per well once the cells were detached),
before being analyzed using a FACSCanto® flow cyt
ometer (BD, Franklin Lakes, NJ). Their mean fluorescence
intensity was analyzed with FACSDiva® software (BD,
Franklin Lakes, NJ), counting 10,000 cells (gated events)
for each sample.

Qualitative Analysis
The cellular uptake of DNA complexed with AuNCs con
jugates was qualitatively assessed using confocal micro
scopy. The labeling of plasmid DNA with the fluorescent
probe fluorescein was performed using a Label IT®
Fluorescein Nucleic Acid Labeling kit, as described by
the manufacturer. PC-3 cells were seeded on coverslips
in 6-well plates at a concentration of 3×105 cells per well
and grown for 24 h at 37 °C. The cells were then treated
with fluorescein-labeled DNA (2.5 μg /well) complexed to
AuNCs-Lf-PEI at weight ratio of 40:1 for 24 h at 37 °C.
Control wells were also prepared with naked DNA or were
left untreated. The cells were then washed twice with
3 mL PBS before being fixed with 2 mL methanol for 10
min at 20 °C. They were then washed again once with
3 mL PBS. Upon staining of the nuclei with Vectashield®
mounting medium containing DAPI, the cells were exam
ined using a Leica TCS SP5® confocal microscope
(Wetzlar, Germany). DAPI (which stained the cell nuclei)
was excited with a 405 nm laser line (emission bandwidth:
415–491 nm), and fluorescein (which labeled the DNA)
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was excited with a 514 nm laser line (emission bandwidth:
550–620 nm).

Cell Viability
The viability of PC-3 prostate cancer cells treated with the
AuNCs conjugates was assessed using a standard MTT assay.
PC-3 cells were seeded in quintuplicate at a density of 10,000
cells/well in 96-well plates and incubated at 37 °C for 24
h. The cells were then treated with various concentrations of
AuNCs conjugates ranging from 2.5 to 200 μg/mL for 72 h at
37 °C and 5% CO2. Following incubation with the treatment,
50 μL of the MTT solution (5 mg/mL in PBS pH 7.4) was
added to the medium and incubated at 37 °C, protected from
light for four hours. The medium was then replaced with 200
μL of DMSO per well to dissolve the precipitated formazan.
The absorbance was measured at 570 nm using a Multiskan
Ascent® plate reader (Thermo Scientific, Waltham, MA).

Statistical Analysis
Results were expressed as means ± standard error of the
mean (SEM). Statistical significance of the data was
assessed by one-way analysis of variance (ANOVA) and
Tukey multiple comparison post-test (Minitab® 17.1.0
software, State College, PE). Differences were considered
statistically significant for P values lower than 0.05.

Results
Characterization of AuNCs Conjugates
Gold nanocages were synthesized via a galvanic replace
ment reaction between Ag nanocubes and chloroauric acid
(HAuCl4). Their large volume batch (800 mL) with Au
content of 597.93 μg/L was used for all the experiments
described in this manuscript.

A

TEM images confirmed the cage-shape, hollow interior
and thin wall of the gold nanocages, with an edge length of
50 nm (Figure 1).
The conjugation of Lf to the surface of AuNCs was
demonstrated using CD and FTIR spectroscopy. The CD
spectrum of Lf exhibited distinctive negative ellipticity peaks
at 244 nm and 283 nm, and a positive ellipticity peak at 309
nm (Figure 2). These peaks were visible in the CD spectrum of
AuNCs-Lf, unlike that of unmodified AuNCs, indicating that
Lf was successfully conjugated to the surface of AuNCs. The
highest molar ellipticity values for the Lf protein and the
conjugates at identical wavelengths (244 nm and 283 nm)
indicated that there was no significant conformational change
in the protein folding upon grafting to the nanocages.
FTIR spectrum of AuNCs-Lf showed the presence of
characteristics peaks at 1645.01 cm−1 and 1534.86 cm−1
(corresponding to amide-I and amide-II of bare Lf) and the
absence of peaks at 1049.94 cm−1 and 1398.97 cm−1
(respectively corresponding to the sulfoxide and sulfate
groups of thiolated lactoferrin), in comparison with the
starting materials (Figure 3). These findings therefore con
firmed the successful conjugation of Lf to the surface of
gold nanocages via Au-S bond and demonstrated the
absence of significant changes on the protein secondary
structure, consistently with the data obtained from CD.
The conjugation of Lf, PEG and PEI to the surface of
AuNCs was further confirmed by UV-Vis spectrometry ana
lysis. AuNCs and AuNCs conjugates exhibited UV-Vis
spectra peaks in the near-infrared region (715 nm, 771 nm,
767 nm and 813 nm respectively for AuNCs, AuNCs-Lf,
AuNCs-Lf-PEG and AuNCs-Lf-PEI) (Figure 4). The redshift of the UV-Vis spectra of AuNCs-Lf, AuNCs-Lf-PEG
and AuNCs-Lf-PEI compared to AuNCs confirmed the

B

200 nm

200 nm

Figure 1 Transmission electron microscopic images of gold nanocages (A) and lactoferrin-bearing gold nanocages (B). Insets: magnification of the samples showing the
morphology of the nanocages.
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Figure 2 CD spectra of lactoferrin (“Lf”), thiolated lactoferrin (“Thiol Lf”), unmodified gold nanocages (“AuNCs”) and lactoferrin-bearing gold nanocages (“AuNCs-Lf”).

surface modification of AuNCs with Lf and indicated an
efficient conjugation of PEG and PEI to AuNCs-Lf.
The conjugation of Lf, Lf-PEG and Lf-PEI to the sur
face of the AuNCs resulted in a slight increase in the
hydrodynamic size of AuNCs-Lf (105.40 ± 0.43 nm),
AuNCs-Lf-PEG (103.30 ± 1.31 nm) and AuNCs-Lf-PEI
(127 ± 1.62 nm) compared to that of AuNCs (88.69 ± 0.66
nm), as determined by DLS measurements. It also
increased the net surface charge of the gold nanocages,
from negative (−20.50 ± 0.38 mV) in the case of unmodi
fied AuNCs, to positive (3.05 ± 0.18 mV, 4.11± 0.38 mV
and 14.10 ± 0.14 mV) for AuNCs-Lf, AuNCs-Lf-PEG and
AuNCs-Lf-PEI, respectively.

Characterization of AuNCs-Lf-DNA
Complex Formation
Gel Retardation Assay
A gel retardation assay confirmed the complete or partial
DNA condensation by AuNCs-Lf and AuNCs-Lf-PEG. At
a AuNCs conjugate:DNA weight ratio of 40:1, DNA was
fully condensed by AuNCs-Lf and AuNCs-Lf-PEG, thus
preventing ethidium bromide to intercalate with DNA. No
free DNA was therefore visible at this ratio (Figure 5A and
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B). In contrast, DNA was partially condensed by AuNCsLf and AuNCs-Lf-PEG at ratios 20:1 and lower. Ethidium
bromide could therefore intercalate with DNA and a band
corresponding to free DNA was visible. On the other hand,
AuNCs-Lf-PEI was able to completely condense DNA at
weight ratios higher than 1:1, resulting in the absence of
a band corresponding to free DNA at these ratios
(Figure 5C). Among the 3 AuNCs conjugates assessed in
this study, AuNCs-Lf-PEI was therefore the most effica
cious in condensing DNA at conjugate:DNA weight ratios
higher than 1:1.

Size and Zeta Potential of the Complexes
AuNCs conjugates complexed with DNA displayed an
average hydrodynamic size smaller than 250 nm at con
jugate:DNA weight ratios higher than 1:1 for AuNCs-Lf
and AuNCs-Lf-PEG, and higher than 5:1 for AuNCs-LfPEI (Figure 6A). The average size of complexes decreased
with increasing weight ratios, from 0.5:1 to 5:1, then
reached a plateau from a 10:1 weight ratio. Among
AuNCs conjugate complexes, AuNCs-Lf-PEI exhibited
the largest complex size of 1.50 ± 0.02 μm at a weight
ratio 0.5:1, while AuNCs-Lf and AuNCs-Lf-PEG com
plexes had smaller size diameter of 464.00 ± 37.37 nm
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A

B

C

Figure 3 FTIR spectra of (A) lactoferrin (“Lf”), (B) thiolated lactoferrin (“Thiol Lf”) and (C) lactoferrin-bearing gold nanocages (“AuNCs-Lf”).

4398

Powered by TCPDF (www.tcpdf.org)

https://doi.org/10.2147/IJN.S316830

DovePress

International Journal of Nanomedicine 2021:16

Dovepress

Almowalad et al

AuNCs
AuNCs-Lf
AuNCs-Lf-PEG
AuNCs-Lf-PEI

Normalized absorbance

1.0

0.8

0.6

0.4

0.2

0.0
400

500

600

700

800

900

1000

Wavelength (nm)
Figure 4 UV-Vis spectra of AuNCs, AuNCs-Lf, AuNCs-Lf-PEG, AuNCs-Lf-PEI conjugates.

and 520.80 ± 28.48 nm respectively at the same ratio. By
contrast, AuNCs-Lf-PEI displayed the smallest complex
size at a conjugate:DNA weight ratio of 40:1, with an
average size of 144.30 ± 6.27 nm. These results demon
strated the AuNCs conjugates ability to condense the DNA
into small complexes with sizes suitable for gene delivery.
Zeta potential experiments showed that the AuNCs
complexes were bearing a slightly negative surface charge
at a conjugate:DNA weight ratio of 0.5:1, indicating that
the negatively charged DNA was not fully complexed with
AuNCs conjugates at this ratio. The zeta potential then
increased as the weight ratios of the complexes increased,
to finally reach the maximum positive charges of 19.90 ±
0.45, 26.70 ± 0.37 and 28.70 ± 0.38 mV for AuNCs-Lf,
AuNCs-Lf-PEG and AuNCs-Lf-PEI respectively, at
a conjugate:DNA weight ratio of 40:1 (Figure 6B). These
results were in good agreement with gel retardation
findings.

Transfection
AuNCs-Lf, AuNCs-Lf-PEG and AuNCs-Lf-PEI com
plexed to DNA were found to increase gene expression
at optimal AuNCs conjugate:DNA weight ratios, compared
with PEI and DOTAP complexes on PC-3 cells (Figure 7).
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Higher gene expression in comparison with PEI com
plex was observed following treatment with AuNCs-Lf
complex at conjugate:DNA ratios of 0.5:1, 1:1, 10:1,
20:1, after treatment with AuNCs-Lf-PEG complex at
ratios of 0.5:1, 5:1, 10:1 and 40:1, and at ratios 0.5:1,
1:1, 20:1 and 40:1 as a result of treatment with AuNCsLf-PEI complex.
The 3 complexes also led to higher gene expression
than DOTAP complex at the ratio of 0.5:1, and at a ratio of
40:1 for AuNCs-Lf-PEI complex.
The highest transfection level was observed following
treatment with AuNCs-Lf-PEI complex at a ratio of 40:1
(2.49 ± 0.10 mU/mL). It was 2.1-fold higher than when
treated with DNA (1.16 ± 0.01 mU/mL), 1.7-fold higher
than with PEI complex (1.46 ± 0.05 mU/mL) and 1.4-fold
higher than following treatment with DOTAP complex
(1.68 ± 0.09 mU/mL).
AuNCs-Lf-PEG complex led to its highest gene
expression level at a conjugate:DNA weight ratio of
0.5:1 (2.43 ± 0.21 mU/mL). This was 2.1-, 1.6- and
1.4-fold higher than that obtained with DNA, PEI and
DOTAP, respectively.
Similarly to AuNCs-Lf-PEG complex, AuNCs-Lf
complex resulted in its highest gene expression at

https://doi.org/10.2147/IJN.S316830

DovePress

Powered by TCPDF (www.tcpdf.org)

4399

Dovepress

Almowalad et al

a conjugate:DNA weight ratio of 0.5:1 (2.22 ± 0.24
mU/mL).
The conjugation of PEI to AuNCs-Lf at its optimal
conjugate:DNA ratio of 40:1 led to an increased gene
transfection (by 1.5-fold) in comparison with unmodified
AuNCs-Lf, unlike what observed following conjugation of
PEG to AuNCs-Lf, which resulted in similar transfection
level. Based on these findings, with consideration of DNA
condensation results, the conjugate:DNA ratios of 40:1
and 0.5:1 were selected for cellular uptake experiments.

A

Cellular Uptake
Quantitative Analysis
The treatment of PC-3 cells with AuNCs-Lf-PEI com
plexed with fluorescein-labeled DNA at a weight ratio of
40:1 resulted in the highest cellular fluorescence (1726.17
± 49.71 arbitrary units (a.u.)), which was 2.3-fold and
6.9-fold higher than that observed with AuNCs-Lf and
AuNCs-Lf-PEG complexes (725.17 ± 33.93 and 247.50
± 3.53 a.u. respectively) at the same ratio (Figure 8). It was
similar to that observed with PEI complex (1803.5 ± 25.42
a.u.) and 8.6-fold higher than that observed after treatment
with DNA solution (199.50 ± 1.31 a.u.). There was no
significant difference in DNA cellular uptake following
treatment with AuNCs-Lf, AuNCs-Lf-PEG and AuNCsLf-PEI complexes at a ratio of 0.5:1.
In addition, the treatment of cells with naked DNA
resulted in a weak DNA uptake, indicating the failure of
DNA to be taken up by prostate cancer cells without the
assistance of a carrier.

B

C

Qualitative Analysis
The cellular uptake of fluorescein-labeled DNA com
plexed with AuNCs-Lf-PEI by PC-3 cells was qualita
tively confirmed using confocal microscopy (Figure 9).
Fluorescein-labeled DNA was disseminated in the cyto
plasm after treatment with AuNCs-Lf-PEI complex. No
co-localization of DNA in the nuclei was visible after
24 h incubation. By contrast, the cells treated with DNA
solution did not show any fluorescein-derived
fluorescence.

Cell Viability
Figure 5 Gel retardation assays of AuNCs-Lf complex (A), AuNCs-Lf-PEG com
plex (B) and AuNCs-Lf-PEI complex (C) at various conjugate:DNA weight ratios
(0.5:1, 1:1, 5:1, 10:1, 20:1, 40:1) (control: DNA solution).
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The treatment of PC-3 cells with AuNCs-Lf, AuNCs-LfPEG and AuNCs-Lf-PEI resulted in a cell viability
higher than 70% at all the tested concentrations
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Figure 6 Size (A) and zeta potential (B) of gold conjugates complexed to DNA at various AuNCs conjugate:DNA weight ratios. Results are expressed as mean ± SEM (n=9).
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Figure 7 Transfection efficacy of AuNCs-Lf, AuNCs-Lf-PEG and AuNCs-Lf-PEI complexes at various conjugates: DNA weight ratios in PC-3 cells. Results are expressed as
the mean ± SEM of three replicates (n=15). *P < 0.05 versus the highest transfection ratio.

(Figure 10). At the maximum treatment concentration
(200 μg/mL), the cell viability was higher following
treatment with AuNCs-Lf-PEG and AuNCs-Lf-PEI
(83.39 ± 1.10% and 79.27 ± 1.63% respectively) than
with AuNCs-Lf (73.12 ± 1.80%). This increase was
attributed to the conjugation of PEG and PEI onto the
AuNCs-Lf. These results therefore suggest that AuNCs
conjugates are safe towards PC-3 cancer cells at the
tested concentrations.

Discussion
The possibility of using gold nanocages as gene delivery
systems for cancer treatment has previously been reported
in conjunction with photothermal therapy and chemother
apeutics, but has never been assessed in isolation and
without external stimulations so far. To explore this pos
sibility, we hypothesize that the conjugation of cancertargeting lactoferrin, PEG or PEI to gold nanocages com
plexed to plasmid DNA would lead to enhanced gene
expression efficacy in PC-3 prostate cancer cells.
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In this study, gold nanocages have been successfully
produced through the galvanic replacement reaction
between Ag nanocubes and chloroauric acid aqueous
solution.22 The production of a large batch of gold nano
cages allowed the elimination of batch-to-batch variations
that could have a detrimental impact on the surface con
jugation of the gold nanocages, their characterization and
in vitro experiments results.26
The conjugation of Lf, PEG and PEI was confirmed by
using CD and FTIR spectroscopy (in the case of Lf con
jugation) and UV-Vis spectrometry analysis (for demon
strating Lf, PEG and PEI grafting). The surface Plasmon
resonance of AuNCs-Lf-PEI was 813 nm, following the
conjugation of PEI to AuNCs-Lf. This red-shifted reso
nance compared with that of unmodified AuNCs was
attributed to the change of refractive index on the surface
of the AuNCs, demonstrating the conjugation of PEI to the
surface of AuNCs. This point of absorption would be
particularly suitable for further promotion of gene delivery
using near-infrared irradiation, as reported by other
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Figure 8 Quantification of the cellular uptake of fluorescein-labeled DNA complexed with AuNCs-Lf, AuNCs-Lf-PEG and AuNCs-Lf-PEI or as a solution, after 24-h
incubation with PC-3 cells, using flow cytometry (n = 6). *P < 0.05 when compared with PEI-DNA.

groups.27 All synthesized gold conjugates in this study
exhibited UV-Vis spectra peaks in the near-infrared region
(700–900 nm), making them appropriate platforms for
imaging and photothermal applications.
Crucially, AuNCs-Lf, AuNCs-Lf-PEG and AuNCs-LfPEI conjugates were all bearing a positive charge, unlike
the unmodified AuNCs, which is of the utmost importance
for permitting the complexation of DNA. The AuNCs
conjugates were all able to complex the negatively charged
DNA through electrostatic interactions, at conjugate:DNA
weight ratios of 5:1 and above to ensure efficient DNA
condensation. The AuNCs conjugate complexes at these
weight ratios displayed suitable size diameter to allow
them to penetrate into the cancer cells, as the cut-off size
for extravasation was found to be 400 nm for most
tumors.28
In addition, the conjugation of AuNCs-Lf with PEG
and PEI enhanced the DNA complexation efficiency, as
AuNCs-Lf-PEG and AuNCs-Lf-PEI conjugates displayed
higher positive charges compared to unmodified AuNCsLf, whose positive charges were mostly due to the pre
sence of positively charged amino acids within Lf.
AuNCs-Lf conjugates therefore have the required physi
cochemical properties for being efficient gene delivery
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systems. It is worth noting that DNA condensation effi
ciency of AuNCs-Lf conjugates could not be assessed
using PicoGreen® assay, due to the fluorescence quenching
properties of gold nanoparticles and the blue color of the
AuNCs samples that interfered with fluorescence intensity
measurements and thereby might have led to false-positive
results.29
The treatment of PC-3 cells with AuNCs-Lf resulted in
enhanced transfection at some conjugates: DNA ratios
compared to the positive controls PEI and DOTAP. This
result was in line with previous publications that reported
that the conjugation of Lf to delivery systems significantly
improved the gene expression in various cancer cell lines.
For instance, Lim et al demonstrated that the conjugation
of Lf to generation 3-diaminobutyric polypropylenimine
dendrimer (DAB) resulted in a 1.4-fold higher gene
expression compared with unconjugated DAB on A431
and B16F10 cells.13 Similarly, Altwaijry et al reported
that treatment of PC-3 cells with DAB-Lf dendriplex led
to 2-fold higher gene expression compared to unmodified
DAB.14 In the present study, gene expression following
treatment with AuNCs-Lf complex was 1.52- and 1.32fold higher than that obtained with PEI and DOTAP,
respectively. Furthermore, the conjugation of AuNCs-Lf
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Figure 9 Confocal microscopy images of the cellular uptake of fluorescein-labeled DNA (2.5 μg per well), either complexed with AuNCs-Lf-PEI at a weight ratio of 40:1 or
in solution after 24-h incubation with PC-3 cells (control: untreated cells). Blue: nuclei stained with DAPI (excitation: 405 nm laser line; bandwidth: 415–491 nm), green:
fluorescein-labeled DNA (excitation: 453 nm laser line; bandwidth: 550–620 nm) (bar: 20 µm).

with PEI and PEG led to an enhanced gene transfection in
comparison with unmodified AuNCs-Lf. Gene expression
following treatment with AuNCs-Lf-PEI and AuNCs-LfPEG complexes at AuNCs conjugate:DNA ratios of 40:1
for AuNCs-Lf-PEI and 5:1 for AuNCs-Lf-PEG was
respectively 1.58-fold and 1.33-fold higher than that
obtained from AuNCs-Lf complex. The grafting of PEG
onto AuNCs-Lf, which increased the transfection effi
ciency by 1.45- and 1.66-fold compared with DOTAP
and PEI, has previously been shown to improve gene
transfection of various delivery systems. For example,
Somani et al reported that PEGylated dendrimers showed
significantly higher transfection levels than nonPEGylated dendrimers in B16F10-Luc, A431, T98G,
DU145 and PC-3-Luc cancer cell lines.20 Additionally,
Luan et al demonstrated that the PEGylation of gold nano
particles led to a significantly increased gene silencing in
PC-3 cells compared to Lipofectamine® 2000, a lipid-
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based transfection reagent used as a positive control.30 It
has recently been reported that the PEGylation of gold
nanoparticles resulted in an increase in transfection effi
ciency and cellular uptake by more than 45%, with low
cytotoxicity, compared with non-PEGylated nanoparticles,
therefore making PEGylated gold nanoparticles suitable
vehicles for DNA delivery.31 The transfection efficiency
following the treatment with AuNCs-Lf-PEI complex was
1.71-fold higher than PEI and 1.48-fold higher than
DOTAP. This result was in accordance with previous
studies that demonstrated that the conjugation of gold
nanoparticles with PEI improves the transfection
efficiency.32,33 The increase of β-galactosidase expression
induced by AuNCs-Lf-PEG and AuNCs-Lf-PEI conju
gates compared to unmodified AuNCs-Lf most likely
resulted from the higher zeta potential of their DNA com
plexes, as a result of the strong correlation between cellu
lar uptake and positive charge density of complexes.34 In
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Figure 10 Cell viability of PC-3 prostate cancer cell treated with AuNCs-Lf, AuNCs-Lf-PEG and AuNCs-Lf-PEI at various concentrations (n=15).

addition to that, the highest transfection efficacy of
AuNCs-Lf-PEI was also due to the proton sponge effect
of PEI, which highly facilitates the endosomal escape.24,35
The cellular uptake of DNA complexed to AuNCs-LfPEI was significantly enhanced in comparison to that
obtained with unmodified AuNCs-Lf, due to the presence
of PEI which mediated proton sponge effect, leading to an
improved endosomal escape of DNA. On the other hand,
AuNCs-Lf-PEG led to a lower level of DNA uptake after
24 h incubation in comparison with AuNCs-Lf, leading to
the hypothesis that the DNA uptake following this treat
ment occurred at a later time, owing to the PEG effect in
reducing cellular uptake that has been previously
reported.36
Future work should assess the interactions of AuNCsLf conjugates with the protein corona for potential in vivo
applications. When exposed to biological fluids, nanopar
ticles tend to interact with biomolecules, leading to the
formation of a complex layer of proteins, the protein
corona. The presence of this protein corona on the surface
of nanoparticles has previously been shown to impact the
cellular internalization of the delivery systems and the
release of the entrapped drugs, modifying the biological
response in vivo.37,38 It is hoped that the surface modifica
tion of AuNCs with Lf, PEG and PEI could minimize

International Journal of Nanomedicine 2021:16

protein adsorption and alter the corona composition, as
a study by Assali et al39 previously reported that functio
nalized gold nanoplatforms displayed less interactions
with proteins and adsorbed less opsonins than their unmo
dified counterparts.

Conclusion
We have demonstrated for the first time that novel gold
nanocages conjugated to lactoferrin, PEI and PEG and
complexed to plasmid DNA led to an increase in gene
expression in PC-3 prostate cancer cells. Cell viability
data demonstrated the low toxicity of these gold con
jugates, with cell viability higher than 70% at all the
tested concentrations. Among the conjugates, gold nano
cages conjugated to lactoferrin and PEI led to the high
est transfection level on PC-3 cells, compared to
DOTAP and PEI. This was probably due to the signifi
cant increase in cellular uptake of DNA in PC-3 prostate
cancer cell line following treatment with this complex,
compared with what that observed in cells treated with
DNA solution. To our knowledge, this is the first time
lactoferrin-bearing gold nanocages have been used to
target prostate cancer cells, leading to enhanced DNA
uptake and gene expression in PC-3 prostate cancer cells
without external stimulation. Lactoferrin-bearing gold
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nanocages conjugates are therefore promising gene
nanocarriers to prostate cancer cells and will be further
investigated, alone or in combination with other cancer
therapy.
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